Himadri Speciality Chemical · NSE: HSCL · BSE: 500184

Q2 FY22 results · Jul–Sep 2021

Himadri Speciality Chemical reported revenue from operations of ₹645.29 crore (up 65.8% from Q2 FY21) and net profit of ₹9.36 crore (down 54.7% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY22Q2 FY21YoYQ1 FY22QoQ
Revenue from operations645.29389.24+65.8%539.75+19.6%
Other income2.525.11−50.7%1.33+89.5%
Total income647.81394.35+64.3%541.08+19.7%
Profit before tax12.2930.04−59.1%17.34−29.1%
Net profit for the period9.3620.66−54.7%14.45−35.2%
Attributable to shareholders of the company9.4120.72−54.6%14.51−35.1%
EPS, basic (₹)0.220.49−55.1%0.35−37.1%
Net margin (%)1.55.32.7
Standalone · ₹ crore
ItemQ2 FY22Q2 FY21YoYQ1 FY22QoQ
Revenue from operations645.28389.24+65.8%539.75+19.6%
Other income2.515.22−51.9%1.23+104.1%
Total income647.79394.46+64.2%540.98+19.7%
Profit before tax14.6325.56−42.8%18.63−21.5%
Net profit for the period11.6916.18−27.8%15.74−25.7%
EPS, basic (₹)0.280.39−28.2%0.38−26.3%
Net margin (%)1.84.22.9
Consolidated
Filed with BSE
13 Nov 2021, 15:50 IST
Board meeting
12 Nov 2021
Period
01 Jul 2021 to 30 Sep 2021
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
13 Nov 2021, 15:50 IST
Board meeting
12 Nov 2021
Period
01 Jul 2021 to 30 Sep 2021
Review status
Unaudited
Source
XBRL filing on BSE